Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-21

Clinical Trial Update: Topical Piroxicam vs Soulagel in the Treatment of Acute Extremity Pain After Emergency Department Discharge [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing topical piroxicam with Soulagel for acute extremity pain after emergency department discharge has completed Phase 2 and Phase 3 stage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soulagel
  • topical piroxicam (piroxicam)

Snippet

Sponsor: University of Monastir | Conditions: Acute Pain | Phase 2, Phase 3 | Status: COMPLETED